GC75966
Casein kinase 1δ-IN-14
Also known as 2-(4-chlorophenyl)-5-(quinazolin-4-yloxymethyl)-1,3,4-oxadiazole
Casein kinase 1δ-IN-14 (compound 481) is a casein kinase inhibitor that can be used to study neurodegenerative diseases such as Alzheimer's disease
ChemicalCAS793722-88-0MW338.75FormulaC17H11ClN4O2
- CAS number
- 793722-88-0
- Molecular weight
- 338.75
- Formula
- C17H11ClN4O2
- Solubility
- DMSO： ＜ 1 mg/mL (insoluble or slightly soluble)
- InChIKey
- OURQZXKGVBMXLD-UHFFFAOYSA-N
- Catalogue number
- GC75966
- Brand
- GLPBIO
Computed properties PubChem CID 2563888 · XLogP 3.5 · TPSA 73.9 Ų · H-bond donors 0
- XLogP
- 3.5
- TPSA
- 73.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 24
SMILES C1=CC=C2C(=C1)C(=NC=N2)OCC3=NN=C(O3)C4=CC=C(C=C4)Cl
Computed descriptors from PubChem (CID 2563888), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il